Infectious Disease News Current Issue
The following articles appeared in the print edition of Infectious Disease News.
Table of Contents
- Incidence rates of certain tick-borne diseases on the rise in US
-
- Adverse events after immunization likely related to alcohol solution used
- Artemisinin-resistant malaria rate increased along Thailand border
- Atypical strain of coxsackievirus caused outbreak of HFMD in four states
- Azithromycin reduced long-term STEC infection
- Back-to-basics approach advocated for preventing nosocomial infections
- Cytomegalovirus IgG linked to subclinical cardiovascular disease in women with HIV
- Discontinuation of malaria prophylaxis led to increased malaria risk in adults with HIV
- HIV/STD counseling in ED linked to less unprotected sex among drug users
-
- Hospitalizations from dengue fever in Pakistan increased since 2006
- Malodorous urine often not necessarily a sign of UTI
- Measles mortality fell markedly; sustained immunization vital to maintain progress
- Ongoing surveillance needed to monitor trends in HPV rates after vaccination
- Pediatric protocol reduced sternal wound infections after cardiac surgery
- Rate of colectomy due to C. difficile low
- Screening general population for hepatitis C appears cost-effective
- Text-message reminders increased flu vaccination rates in children
-
- US Measles cases reach 15-year high
- Vaccine significantly decreased herpes incidence in older adults
- Valve infection rate high in cardiac device infective endocarditis
- HIV/AIDS science in 2012 Paul A. Volberding, MD
- C. trachomatis prevalent among young, pregnant women
- Circumcision program reduced HIV acquisition in non-Muslim men
- Diabetes associated with more TB symptoms, adverse effects
- Infection prevention, control policies inadequate to stop MRSA spread
-
- Linezolid showed promise in extensively drug resistant TB
- Metformin prevented plaque progression in HIV/metabolic syndrome patients
- New test detects C difficile more rapidly
- Screening all hospital admissions for MRSA unlikely to be cost-effective